FGFR3 GENE MUTATION
Clinical trials for FGFR3 GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new FGFR3 GENE MUTATION trials appear
Sign up with your email to follow new studies for FGFR3 GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise for tough bladder cancer before surgery
Disease control OngoingThis study tests a pill called erdafitinib in people whose bladder cancer has come back after standard treatments like BCG or chemotherapy. Only patients with a specific gene change (FGFR3 mutation) in their tumor can join. The goal is to see if the pill can shrink or eliminate t…
Matched conditions: FGFR3 GENE MUTATION
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 17, 2026 00:51 UTC
-
New drug targets Hard-to-Treat cancers with FGFR3 gene changes
Disease control OngoingThis study tests an experimental drug called TYRA300 in people with advanced bladder cancer or other solid tumors that have a specific change in the FGFR3 gene. The goal is to find the safest dose and see if the drug can shrink tumors. About 310 adults whose cancer has not respon…
Matched conditions: FGFR3 GENE MUTATION
Phase: PHASE1, PHASE2 • Sponsor: Tyra Biosciences, Inc • Aim: Disease control
Last updated May 17, 2026 00:50 UTC